Reckitt Benckiser Group Plc (RB) Reveals 300 Million Pound Latin America Tie-In

Page 1 of 2

LONDON — Shares in Reckitt Benckiser Group Plc (LON:RB) lifted this morning following the group’s positive fourth-quarter and full-year earnings release, with management declaring that its strategy is “well on track.”

The earnings release also reported a three-year collaboration agreement with U.S. biopharmaceutical company Bristol Myers Squibb Co. (NYSE:BMY), for a number of market-leading over-the-counter consumer health-care brands in Latin America, including Brazil and Mexico.

The arrangement includes personnel, supply contracts, and an option to acquire legal title to the related intellectual property at the end of the collaboration period for a multiple of earnings.

Bristol Myers Squibb Co. (NYSE:BMY)Reckitt saw net revenue for Q4 hit 2.48 billion pounds, up 2% on actual exchange rates and 6% on constant rates. The full-year figure was 9.58 billion pounds, up 1% actual and 4% constant.

Like-for-like growth increased 7% in the fourth quarter, and 5% across the full year — well ahead of its market growth, driven by emerging-market areas and Europe/North America (ENA). Additionally, the company’s sales were boosted by “higher incidences of cold and flu.”

Health and hygiene led Reckitt’s growth, with a broad range of products, including Durex, Gaviscon, Strepsils, Dettol, Lysol, Harpic, and Finish. Chief Executive Officer Rakesh Kapoor commented, “We are laying the foundations for RB to succeed in a world where health and hygiene play an increasingly important role in terms of both economic and social development.”

Kapoor continued:

We enhanced our focus on our 16 power markets, many of which are in the emerging-market areas that now represent 44% of our core net revenue. I am very pleased that our 2012 achievements demonstrate the strength of this strategy and its ability to create sustainable value for all of our stakeholders.

While much has yet to be done and markets remain challenging, we approach 2013 with the confidence that we have the right strategic focus, the right organization and culture, and with the right innovation platforms. We are particularly excited by our entry into the vitamins, minerals, and supplements market with the acquisition of Schiff. We are supporting our brands with more and better-quality brand equity investment to deliver further growth in an increasingly competitive consumer environment.

We remain committed to our goal of net revenue growth on average +200bps per annum above our market growth, and moderate operating margin expansion (ex RBP). For 2013, we are targeting net revenue growth of +5-6% including acquisitions and disposals announced to date. Given the early achievement of cost savings in 2012, we expect to maintain operating margins in 2013. These targets exclude RBP.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!